TNF and rheumatoid arthritis: The introduction of biologic therapies, including tumor necrosis factor inhibitor (TNFi) medications, for the treatment of moderate to severe RA has made remission more achievable than was previously seen with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), e.g., methotrexate.